DelveInsight’s “Sickle Cell Disease Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Sickle Cell Disease, historical and forecasted epidemiology as well as the Sickle Cell Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Sickle Cell Disease market report provides current treatment practices, emerging drugs, Sickle Cell Disease market share of the individual therapies, current and forecasted Sickle Cell Disease market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Sickle Cell Disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Sickle Cell Disease market.
Some of the key facts of the Sickle Cell Disease Market Report:
Key benefits of the Sickle Cell Disease Market report:
Got queries? Click here to know more about the Sickle Cell Disease Market Landscape
Sickle Cell Disease Overview
Sickle cell disease (SCD) is a group of inherited red blood cell disorder caused by a structural abnormality of hemoglobin called sickle hemoglobin (HbS) which encodes hemoglobin subunit β. HbS is inherited in an autosomal recessive way and can occur due to homozygosity for HbS (HbSS). HbS is functional and soluble when oxygenated, but upon deoxygenation it polymerizes, leading to the generation of deformed red blood cells known as sickled cells and dense erythrocytes. According to the Centre for Disease Control and Prevention (CDC), it is estimated that SCD affects approximately 100,000 Americans. It occurs among about 1 out of every 365 Black or African-American births, about 1 out of every 16,300 Hispanic-American births, and about 1 in 13 Black or African-American babies is born with sickle cell trait.
SCD causes a range of acute and long-term complications, requiring a multi-disciplinary approach, involving various medical specialists. Care of patients with sickle cell disease is largely supportive with hydroxyurea representing the only widely used drug which modifies disease pathogenesis. Painful vaso-occlusive events are the most common complication experienced by both children and adults with sickle cell disease and there are few treatment options to prevent the development of these events. Most are managed with traditional supportive care measures (i.e. aggressive hydration, anti-inflammatory and narcotic analgesics). The current therapies used to prevent the complications of the disease vary in their effectiveness and are associated with serious risks and tolerability issues. Besides this, SCD presents with large unmet medical needs, with no disease-modifying treatment.
Sickle Cell Disease Epidemiology Insights:
Sickle Cell Disease Epidemiological Segmentation
Sickle Cell Disease Market Outlook
The Sickle Cell Disease market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Sickle Cell Disease market trends by analyzing the impact of current Sickle Cell Disease therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of Sickle Cell Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Sickle Cell Disease market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Sickle Cell Disease market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @Sickle Cell Disease Market Landscape
Sickle Cell Disease Key Companies
Sickle Cell Disease Therapies
Table of Contents
Click here to read more about Sickle Cell Disease market
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/